Cargando…

Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors

Cyclin-dependent kinase 2 (CDK2) is a potential target for treating cancer. Purine heterocycles have attracted particular attention as the scaffolds for the development of CDK2 inhibitors. To explore the interaction mechanism and the structure–activity relationship (SAR) and to design novel candidat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Gaomin, Ren, Yujie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278423/ https://www.ncbi.nlm.nih.gov/pubmed/30423939 http://dx.doi.org/10.3390/molecules23112924

Ejemplares similares

Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers
por: Kuchukulla, Ratnakar Reddy, et al.
Publicado: (2022)

Design and synthesis of chalcone derivatives as potential non-purine xanthine oxidase inhibitors
por: Bui, Trung Huu, et al.
Publicado: (2016)

Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors
por: Skácel, Jan, et al.
Publicado: (2023)

Designing and Synthesis of New Isatin Derivatives as Potential CDK2 Inhibitors
por: Czeleń, Przemysław, et al.
Publicado: (2022)

Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors
por: Ismail, Hoda S., et al.
Publicado: (2023)

Purine and Purine Isostere Derivatives of Ferrocene: An Evaluation of ADME, Antitumor and Electrochemical Properties
por: Rep, Valentina, et al.
Publicado: (2020)

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer
por: Liang, Hanzhi, et al.
Publicado: (2022)

Exploiting Purine as an Internal Standard for SERS Quantification of Purine Derivative Molecules Released by Bacteria
por: Cheng, Ho-Wen, et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors
por: Wang, Suhua, et al.
Publicado: (2022)

Investigation of 8-Aza-7-Deaza Purine Nucleoside Derivatives
por: Ren, Hang, et al.
Publicado: (2019)

Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights
por: Eldehna, Wagdy M., et al.
Publicado: (2022)

Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor
por: Whittaker, Steven R., et al.
Publicado: (2018)

Design and Synthesis of New Modified Flexible Purine Bases as Potential Inhibitors of Human PNP
por: Khandazhinskaya, Anastasia, et al.
Publicado: (2023)

Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAF(V600E)
por: El-Kalyoubi, Samar A., et al.
Publicado: (2023)

Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors
por: Faris, Abdelmoujoud, et al.
Publicado: (2023)

Purine nucleoside phosphorylase inhibitors - an immunotherapy with novel mechanism of action for the treatment of melanoma
por: Bantia, Shanta
Publicado: (2015)

Design, Synthesis, and In Vitro Antiproliferative Activity of Hydantoin and Purine Derivatives with the 4-Acetylphenylpiperazinylalkyl Moiety
por: Zagórska, Agnieszka, et al.
Publicado: (2021)

The Purins
por: Hopkins, Henry Reed
Publicado: (1910)

Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity
por: Abdel-Rahman, Adel A.-H., et al.
Publicado: (2021)

Glutathione-Mediated Neuroprotective Effect of Purine Derivatives
por: Matsumura, Nobuko, et al.
Publicado: (2023)

Design, Synthesis, and Molecular Docking of Paracyclophanyl-Thiazole Hybrids as Novel CDK1 Inhibitors and Apoptosis Inducing Anti-Melanoma Agents
por: Aly, Ashraf A., et al.
Publicado: (2020)

Molecular mechanism of G(1) arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
por: Tao, Yan-Fang, et al.
Publicado: (2017)

FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2012)

Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
por: Majumdar, Abir, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors
por: Yang, Bo, et al.
Publicado: (2023)

Tricyclic Nucleobase Analogs and Their Ribosides as Substrates and Inhibitors of Purine-Nucleoside Phosphorylases III. Aminopurine Derivatives
por: Stachelska-Wierzchowska, Alicja, et al.
Publicado: (2020)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies
por: Hashem, Heba E., et al.
Publicado: (2023)

THE PURINES AND PURINE METABOLISM OF SOME TUMORS IN DOMESTIC ANIMALS
por: Long, Esmond R.
Publicado: (1913)

Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling
por: El-Kalyoubi, Samar, et al.
Publicado: (2023)

In Vitro Biotransformation, Safety, and Chemopreventive Action of Novel 8-Methoxy-Purine-2,6-Dione Derivatives
por: Marć, Małgorzata Anna, et al.
Publicado: (2017)

Synthesis of New 5′-Norcarbocyclic Aza/Deaza Purine Fleximers - Noncompetitive Inhibitors of E.coli Purine Nucleoside Phosphorylase
por: Khandazhinskaya, Anastasia, et al.
Publicado: (2022)

Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
por: Kassab, Asmaa E., et al.
Publicado: (2021)

Hydrogen-Bonding Interactions of 8-Substituted Purine Derivatives
por: Osifová, Zuzana, et al.
Publicado: (2023)

Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90
por: Shin, Sang Chul, et al.
Publicado: (2020)

2D-QSAR and docking study of a series of coumarin derivatives as inhibitors of CDK (anticancer activity) with an application of the molecular docking method
por: Kasmi, Rania, et al.
Publicado: (2020)

Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes
por: Wang, Lifei, et al.
Publicado: (2022)

Quinazoline Derivatives Designed as Efflux Pump Inhibitors: Molecular Modeling and Spectroscopic Studies
por: Udrea, Ana-Maria, et al.
Publicado: (2021)

Versatile synthesis and biological evaluation of novel 3’-fluorinated purine nucleosides
por: Ren, Hang, et al.
Publicado: (2015)

Structure-guided design of purine-based probes for selective Nek2 inhibition
por: Coxon, Christopher R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gnotvueufclo1domc30vvcu7av